journal of men's health
Volume 6, Issue 4 , Pages 345-353 , December 2009

Helping prostate cancer patients understand the causes of anxiety and depression: comparing cancer-caused vs patient response events

  • Christopher F. Sharpley, PhD

      Affiliations

    • Centre for Bioactive Discovery in Health & Ageing, University of New England, New South Wales, Australia
    • Corresponding Author InformationCorresponding author.
    • ,
  • Vicki Bitsika, PhD

      Affiliations

    • Bond University, Gold Coast, Queensland, Australia
    • ,
  • David R.H. Christie, MB, ChB

      Affiliations

    • Premion, Queensland, Australia

Received 30 March 2009 ,Accepted 11 August 2009.

References 

  1. Kronenwetter C, Weidner G, Pettengill E, Marlin R, Crutchfield L, McCormack P, et al. A qualitative analysis of interviews of men with early stage prostate cancer. Canc Nurs. 2005;28:99–107
  2. Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psycho-Oncology. 2001;10:19–28
  3. Llorente MD, Burke M, Gregory G, Bosworth H, Grambow S, Horner R, et al. Prostate cancer: a significant risk factor for late-life suicide. Am J Geriatr Psychiatry. 2005;13:195–201
  4. Steginga SK, Occhipinto S, Gardner RA, Yaxley J, Heathcote P. Prospective study of men's psychological and decision-related adjustment after treatment for localised prostate cancer. Urology. 2004;63:751–756
  5. Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont J, et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer. 2004;90:2297–2304
  6. Couper JW, Bloch A, Love A, Duchesne G, Macvean M, Kissane DW. The psychosocial impact of prostate cancer on patients and their partners. Med JAust. 2006;185:428–432
  7. Bennett G, Badger TA. Depression in men with prostate cancer. Onc Nurs Forum. 2005;32:545–556
  8. Katz A. Quality of Life for men with prostate cancer. Canc Nurs. 2007;30:302–308
  9. Sharpley CF, Bitsika V, Christie DRH. Psychological distress among prostate cancer patients: fact or fiction?. Clin Med Onc. 2008;2:563–572
  10. Nelson CJ. An argument to screen for distress in men diagnosed with early-stage prostate cancer. Nature Clin Pract Urol. 2006;3:586–587
  11. Lintz K, Moynihan C, Stenginga S, Norman A, Eeles R, Huddart R, et al. Prostate cancer patients’ support and psychological care needs: survey from a non-surgical oncology clinic. Psycho-Oncology. 2003;12:769–783
  12. Thomas BC, Thomas I, Nandamohan V, Nair MK, Pandey M. Screening for distress can predict loss of follow-up and treatment in cancer patients: results of development and validation of the Distress Inventory for Cancer Version 2. Psycho-Oncology. 2009;18(5):524–533
  13. Christie KM, Meyerowitz BE, Giedzinska-Simons A, Gross M, Agus DB. Predictors of affect following treatment decision-making for prostate cancer: conversations, cognitive processing, and coping. Psycho-Oncology. 2009;18(5):508–514
  14. Greenberg DB. The Somerset/Stout/Miller article reviewed. Oncology. 2004;18:1035–1036
  15. Bear MF, Connors BW, Paradiso MA. Neuroscience: Exploring the Brain. Philadelphia, PA: Lippincott, Williams & Wilkins; 2007;
  16. Nemeroff CB. The neurobiology of depression. Sci Am. 1998;278:42–49
  17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Arlington, VA: American Psychiatric Association (APA); 2000;
  18. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, et al Dynamic regulation of mitochondrial function by glucorticoids. Proc Natl Acad Sci. 2009;106:3543–3548
  19. Fiocco AJ, Wan N, Weekes N, Pim H, Lupien SJ. Diurnal cycle of salivary cortisol in older adult men and women with subjective complaints of memory deficits and/or depressive symptoms: relation to cognitive functioning. Stress. 2006;9:143–152
  20. Nutt D. Anxiety and depression: individual entities or two sides of the same coin?. Int J Psychiatry Clin Pract. 2004;8:19–24
  21. Zinbarg RE, Barlow DH, Liebowitz M, Street L, Broadhead E, Katon W, et al. The DSM-IV field trial for mixed anxiety depression. Am J Psychiatry. 1994;151:1153–1162
  22. Hersch J, Juraskova I, Price M, Mullan B. Psychosocial interventions and quality of life in gynaecological patients: a systematic review. Psycho-Oncology. 2009;18(8):795–810
  23. Peeters C, Stewart A, Segal R, Wouterloot E, Scott CG, Aubry T. Evaluation of a cancer exercise program: patient and physical benefits. Psycho-Oncology. 2009;18(8):898–902
  24. Goedendorp MM, Gielissen MF, Verhagen CA, Mieijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst. Rev. 2009;21(1):CD006953
  25. Sharpley CF, Bitsika V, Christie DRH. Causal “mapping” of depression among prostate cancer patients: a preliminary interview study. jmhg. 2007;4:402–408
  26. Sharpley CF, Bitsika V, Christie DRH. Understanding the causes of depression among prostate cancer patients: development of the Effects of Prostate Cancer on Lifestyle Questionnaire. Psycho-Oncology. 2009;18:162–168
  27. Zung WWK. A rating instrument for anxiety disorders. Psychosomatics. 1971;12:371–379
  28. Sharpley CF, Rogers HJ. Naïve versus sophisticated item-writers for the assessment of anxiety. J Clin Psychol. 1985;41:58–62
  29. Sharpley CF, Christie DRH. An analysis of the psychometric profile and frequency of anxiety and depression in Australian men with prostate cancer. Psycho-Oncology. 2007;16:660–667
  30. Zung WWK. How normal is anxiety? Current Concepts. Durham, NC: Upjohn; 1980;
  31. Zung W. From art to science: the diagnosis and treatment of depression. Arch Gen Psychiatry. 1973;29:328–337
  32. DeJonghe J, Baneke J. The Zung self-rating depression scale: a replication study on reliability, validity and prediction. Psychol Rep. 1989;64:833–834
  33. Gabrys J, Peters K. Reliability, discriminant and predictive validity of the Zung Self-Rating Depression Scale. Psychol Rep. 1985;57:1091–1096
  34. Schaefer A, Brown J, Watson C, Plenel D, DeMotts J, Howard M, et al. Comparison of the validities of the Beck, Zung and MMPI depression scales. J Consult Clin Psychol. 1985;53:415–418
  35. Anastasi A. Psychological Testing. 5th edn.. New York: Collier Macmillan; 1982;
  36. Pallant J. SPSS Survival Manual. 3rd edn.. Sydney: Allen & Unwin; 2007;
  37. Tabachnik BG, Fidell LS. Using Multivariate Statistics. 4th edn.. Boston: Allyn & Bacon; 2001;
  38. Cooksey RW. Illustrating Statistical Procedures. Prahan, Australia: Tilde University Press; 2007;
  39. Bolling MY, Kolenberg RJ, Parker CR. Behavior analysis and depression. In:  Dougher MJ editors. Clinical Behavior Analysis. Reno, NV: Context Press; 1999;p. 127–153
  40. Judd LL, Paulus MP, Wells KB, Rappaport MH. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am J Psychiatry. 1996;153:1411–1417
  41. Wilson GT. Behavior therapy. In:  Corsini RJ,  Wedding D editor. Current Psychotherapies. 8th edn.. Belmont, CA: Thomson Brooks/Cole; 2008;p. 223–262
  42. Sadek N, Bona J. Subsyndromal symptomatic depression: a new concept. Depress Anxiety. 2000;12:30–39
  43. Rogers CR, Sanford RC. Client-centered psychotherapy. In:  Kaplan HI,  Sadock BJ,  Friedman AM editor. Comprehensive Textbook of Psychiatry. 4th edn.. Baltimore: William & Wilkins; 1985;p. 1374–1388
  44. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Theory of Depression. New York: Guilford; 1979;

PII: S1875-6867(09)00328-5

doi: 10.1016/j.jomh.2009.08.193

journal of men's health
Volume 6, Issue 4 , Pages 345-353 , December 2009

Article Tools